Study the IL6, IL2 and Biochemical Marker Associated with Covid-19 Patients in Diyala Governorate/Iraq
NeuroQuantology
; 20(5):1203-1211, 2022.
Article
in English
| EMBASE | ID: covidwho-1918157
ABSTRACT
The current study was performed at Baqubah General Hospital /Diyala which included 60 patients with CoV-19 distributed on 27 males and 33 females, while 30 individuals not infected with CoV-19 (control group) who were aged between 20-65 and from a period between September 5 to December 15 /2021. All samples were already diagnosed with CoV-19 infection by using RT-PCR and IgM/IgG Rapid Test Kit. Blood samples and a nasopharyngeal swab were taken from the patients and control group to test for;iL-6, iL2, blood urea, serum creatinine and LDH. The study revealed the infection with CoV-19 showed the highest levels of iL-6 and iL2 were(71.88 and177.50) pg/ml levels respectively, the biochemical analysis also showed the highest levels of each blood urea, serum creatinine and LDH were (35.40, 0.80, 330.95) respectively.
adult; adverse drug reaction; article; biochemical analysis; blood sampling; controlled study; coronavirus disease 2019; creatinine blood level; female; gene expression; general hospital; human; human tissue; Iraq; major clinical study; male; nasopharyngeal swab; protein expression; rapid test; side effect; urea blood level; biochemical marker; endogenous compound; immunoglobulin G; immunoglobulin M; interleukin 2; interleukin 6
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
NeuroQuantology
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS